Hyperthyroidism resident survival guide: Difference between revisions

Jump to navigation Jump to search
Line 110: Line 110:


==Treatment==
==Treatment==
Thyroid storm may lead to irreversible cardiovascular collapse and death if proper treatment is not initiated in the Emergency Department.<ref name="pmid2680469">{{cite journal| author=Roth RN, McAuliffe MJ| title=Hyperthyroidism and thyroid storm. | journal=Emerg Med Clin North Am | year= 1989 | volume= 7 | issue= 4 | pages= 873-83 | pmid=2680469 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2680469  }} </ref>
Shown below is an algorithm summarizing the treatment of [[Graves' disease]] according to the American Thyroid Association guidelines.
For patients with clinical features of  thyroid storm,we start immediate treatment with a beta blocker And then either 200 mg of propylthiouracil (PTU) every four
hours or methimazole (orally 20 mg every four to six hours). PTU is preferred over methimazole due to the effect
of PTU to decrease the conversion from T4 to T3. Iodine administration should be postponed for at least one hour after administration of thionamide
to prevent the iodine from being used as a substrate for new hormone synthesis.
We also administer glucocorticoids (hydrocortisone, 100 mg intravenously every
eight hours) in patients with thyroid storm clinical features.Supporting therapy and the detection and treatment of any precipitating factors ( e.g.
infection) in addition to specific thyroid therapy can be vital to the eventual outcome.The infection needs to be detected and treated,
and the aggressive correction of hyperpyrexia is required.
Acetaminophen should be used instead of aspirin, as the latter will
increase concentrations of serum-free T4 and T3 by interfering with protein binding.
 
Once clinical improvement is shown, iodine therapy may
be discontinued and glucocorticoids may be tapered and discontinued.Beta blockers can be stopped but only after
the tests on thyroid function have returned to normal.To maintain the euthyroidism, the
dosage of thionamides should be titrated. PTU should be changed to methimazole due to the
improved safety profile of methimazole and higher compliance rates. Patients who fail medical therapy should be treated with therapeutic plasma exchange or thyroidectomy. The mortality of thyroid storm is currently reported at 10%.<ref name="pmid23920160">{{cite journal| author=Chiha M, Samarasinghe S, Kabaker AS| title=Thyroid storm: an updated review. | journal=J Intensive Care Med | year= 2015 | volume= 30 | issue= 3 | pages= 131-40 | pmid=23920160 | doi=10.1177/0885066613498053 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23920160  }} </ref> 
 





Revision as of 19:04, 9 January 2021

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Pervaiz Laghari, MD[2]

Overview

Hyperthyroidism and thyroid storm are disease states that result from thyroid hormone-induced hypermetabolism. The excess thyroid hormone is released from the thyroid gland as a result of excess thyroid hormone production, or by processes that disrupt the follicular structure of the gland with subsequent release of stored hormone [1]. Most patients with severe hyperthyroidism present with a dramatic symptom constellation. Hyperthyroidism's typical symptoms include palpitations,heat intolerance, increased bowel movement frequency tremor, anxiety, weight loss despite normal or increased appetite and shortness of breath.Goiter is commonly found on physical examination.

Specific organ systems

Cardiovascular Heart rate is increased,Systolic hypertension ,pulse pressure is widened, congestive heart failure, Atrial fibrillation
Neuropsychiatric Anxiety, tremor, restlessness, irritability,insomnia,psychosis, agitation,depression, seizures
Respiratory Dyspnea, tracheal obstruction, exacerbate underlying asthma,Pulmonary arterial systolic pressure is increased
Gastrointestinal Weight loss,hyperphagia,hyperdefecation and malabsorption
Skin Sweating,Onycholysis,Hyperpigmentation,Thinning of the hair
Eyes Stare and lid lag, ophthalmopathy.
Genitourinary Urinary frequency and nocturia
Hematologic Normochromic, normocytic anemia
Neck Thymic enlargement
Bone Osteoporosis and an increased fracture risk

Causes

Life Threatening Causes

Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.

Common Causes

Diagnosis

Shown below is an algorithm summarizing the diagnosis of hyprthyroidism according to the American Thyroid Association guidelines[5]. Serum TSH measurement has the highest sensitivity and specificity of any single blood test used in the evaluation of suspected thyrotoxicosis and should be used as an ini-tial screening test . However, when thyrotoxicosis is strongly suspected, diagnostic accuracy improves when aserum TSH, free T4, and total T3 are assessed at the initial evaluation. Serum TSH levels are considerably more sensitive than direct thyroid hormone measurements for assessing thyroid hormone excess. In overt hyperthyroidism, serum free T4,T3,or both are elevated, and serum TSH is subnormal (usually<0.01mU/L ina third-generation assay). In mild hyperthyroidism, serum T4 and free T4 can be normal, only serum T3 may be elevated, and serum TSH will be low or undetectable. The diagnosis of a thyrotoxic crisis is made entirely on the clinical findings. Most importantly, there is no difference in thyroid hormone levels between patients with "uncomplicated" thyrotoxicosis and those undergoing a thyroid storm.[6]


 
 
 
 
 
 
 
Clinical assessment of signs & symptoms for hyperthyroidism:
  • Tachycardia
  • Palpitations
  • Anxiety, insomnia
  • Fine tremors in outstretched hands
  • Heat intolerance
  • Diaphoresis
  • Weight loss
  • irregular pulse (in atrial fibrillation)
  • dyspnea
  • orthopnea
  • brisk deep tendon reflexes
  • proximal muscle weakness
  • pretibial myxedema (Graves’ disease)
  • lid lag, lid retraction, decrease lacrimation (thyroid eye disease)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Measure serum Thyroid stimulating hormone levels
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Low TSH
 
 
 
 
 
 
 
High TSH
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mild hyperthyroidism: Serum T4 and T3 values in normal range or only T3 levels are elevated.
 
 
 
Overt hyperthyroidism: Both serum T3 and T4 levels elevated
 
 
 
 
Elevated serum T4 and T 3 levels
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Perform thorough physical examination of thyroid gland and look for signs for thyroid eye disease. Thyroid gland diffusely enlarged with symmetrical hypertrophy and new onset of ocular symptoms
 
 
 
 
 
Repeat TSH levels in serial dilution
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Yes. Graves' disease
 
No
 
 
Positive
 
 
Negative
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Measure serum assays of TRAb and radioactive iodine uptake thyroid scan
 
 
 
High TSH levels due to hetrophilic antibodies
 
 
Look out for pituitary lesion
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Measurement of serum levels of human anti-mouse antibodies
 
 
 
* Perform MRI Brain
  • High ratio of the serum level of alpha subunit of the pituitary glycoprotein hormone
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Diffuse increase in iodine uptake
 
 
 
Localized increase in iodine uptake
 
 
 
Subnormal or absent uptake of iodine
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Graves' disease
 
 
Toxic nodular goiter
 
Subacute thyroiditis/ Postpartum thyroiditis
 
Factitious ingestion of thyroid hormones
 
Excess intake of iodine recently
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
High levels of thyroglobulin in serum
 
Low thyroglobulin levels
 
Measure spot urine iodine or 24 hour urine iodine level
 

Treatment

Shown below is an algorithm summarizing the treatment of Graves' disease according to the American Thyroid Association guidelines.


Drug List

Drug Initial daily dose Mechanisim of action
Beta blocker Propranolol 60 to 80 mg orally every four to six hours, Control the symptoms and signs
Thionamide PTU 200 mg every four hours or methimazole,20 mg orally every four to six hours Block new hormone synthesis
Iodine (Lugol's) solution, 10 drops (6.25 mg iodide/iodine per drop [0.05 mL]) three times daily Block the release of thyroid hormone
Glucocorticoids Hydrocortisone, 100 mg intravenously every eight hours Reduce T4-to-T3 conversion, promote vasomotor stability, possibly reduce the autoimmune process in Graves' disease, and possibly treat an associated relative adrenal insufficiency
An iodinated radiocontrast agent 0.5 to 1 g once daily. inhibit the peripheral conversion of T4 to T3
Bile acid sequestrants Cholestyramine,4 g orally four times daily Decrease enterohepatic recycling of thyroid hormones

Do's

  • Start immediate treatment with a beta blocker
  • Acetaminophen should be used instead of aspirin
  • Iodine administration should be postponed for at least one hour after administration of thionamide
  • Propranolol, PTU, and methimazole can be administered through a nasogastric tube

Don'ts

  • The content in this section is in bullet points.

References

  1. Roth RN, McAuliffe MJ (1989). "Hyperthyroidism and thyroid storm". Emerg Med Clin North Am. 7 (4): 873–83. PMID 2680469.
  2. Kravets I (2016). "Hyperthyroidism: Diagnosis and Treatment". Am Fam Physician. 93 (5): 363–70. PMID 26926973.
  3. Vanderpump MP (2011). "The epidemiology of thyroid disease". Br Med Bull. 99: 39–51. doi:10.1093/bmb/ldr030. PMID 21893493.
  4. Pearce EN, Farwell AP, Braverman LE (2003). "Thyroiditis". N Engl J Med. 348 (26): 2646–55. doi:10.1056/NEJMra021194. PMID 12826640.
  5. "Correction to: Thyroid 2016;26:1343-1421. DOI: 10.1089/thy.2016.0229". Thyroid. 27 (11): 1462. 2017. doi:10.1089/thy.2016.0229.correx. PMC 5672663. PMID 29035639.
  6. Karger S, Führer D (2008). "[Thyroid storm--thyrotoxic crisis: an update]". Dtsch Med Wochenschr. 133 (10): 479–84. doi:10.1055/s-2008-1046737. PMID 18302101.


Template:WikiDoc Sources